City

Seattle (2)

Condition

Myxoid Liposarcoma (2)

Round Cell Liposarcoma (2)

Metastatic Soft Tissue Sarcoma (1)

Stage III Soft Tissue Sarcoma AJCC v7 (1)

Stage IV Soft Tissue Sarcoma AJCC v7 (1)

Synovial Sarcoma (1)

Unresectable Soft Tissue Sarcoma (1)

Overall Status

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

early phase 1 (1)

phase 2 (1)

Sponsor

Fred Hutchinson Cancer Center (2)

Collaborator

National Cancer Institute (NCI) (2)

Horizon Pharma USA, Inc. (1)

Janssen Pharmaceuticals (1)

Intervention

laboratory biomarker analysis (2)

biopsy (1)

recombinant interferon gamma (1)

trabectedin (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

round cell liposarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Myxoid Liposarcoma, Round Cell Liposarcoma, Stage III Soft Tissue Sarcoma AJCC v7 Trial in Seattle (procedure, other, drug)

Withdrawn

Myxoid Liposarcoma
+5 more

Biopsy
+2 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Sep 6, 2019

Myxoid Liposarcoma, Round Cell Liposarcoma, Synovial Sarcoma Trial in Seattle (Laboratory Biomarker Analysis, Recombinant

Terminated

Has Results

Myxoid Liposarcoma
+2 more

Laboratory Biomarker Analysis
Recombinant Interferon Gamma

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Jun 19, 2019